Parmigiani, S <br/><br/>
Palivizumab in infants with gestational age < or = 28 weeks and bronchopulmonary dysplasia.  [electronic resource] 

 -  Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma  2001 
 - 109-13 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antiviral Agents--administration & dosage<br/>Birth Weight<br/>Bronchopulmonary Dysplasia--drug therapy<br/>Chi-Square Distribution<br/>Data Interpretation, Statistical<br/>Female<br/>Gestational Age<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Injections, Intramuscular<br/>Interviews as Topic<br/>Male<br/>Palivizumab<br/>Respiratory Syncytial Virus Infections--prevention & control<br/>Surveys and Questionnaires<br/>Time Factors